Utah Medical Products, Inc.
UTMD
Market Cap$248.61M
Close$
$147.50
123% upside
Current Fair Value
123% upsideUndervalued by 123% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $248.61 Million |
|---|---|
| Enterprise Value | $337.83 Million |
| Dividend Yield | $1.1839 (1.68%) |
| Earnings per Share | $0.0 |
| Beta | 0.69 |
| Outstanding Shares | 3,528,426 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | -0.0 |
| Price to Sales | 5.09 |
| Price to Book Ratio | 1.89 |
| Enterprise Value to Revenue | 7.25 |
| Enterprise Value to EBIT | 25.12 |
| Enterprise Value to Net Income | 21 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Utah Medical Products, Inc.
CEO: Kevin Cornwell Utah Medical Products, Inc. with particular interest in health care for women and their babies, develops, manufactures and markets a broad range of disposable and reusable specialty medical devices recognized by clinicians in over a hund...